ATRenew (RERE) Executive President discloses extensive low-priced option grants

Rhea-AI Filing Summary

ATRenew Inc. Executive President Wang Yongliang filed an initial ownership report detailing multiple stock option awards on Class A ordinary shares. The options generally carry a $0.1000 exercise price and expire between 2029 and 2035. One grant covers 182,605 shares awarded on January 1, 2022, vesting in equal 1/4 installments each January 1 over four years, subject to continued service.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Yongliang

(Last) (First) (Middle)

12TH FLOOR, NO 6 BUILDING

433 SONGHU ROAD

(Street)

SHANGHAI 200433

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ATRenew Inc. [ RERE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive President

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	06/03/2020	06/03/2029	Class A ordinary share	3,189	$0.1	D
Options (Right to Buy)	06/03/2021	06/03/2029	Class A ordinary share	5,710	$0.1	D
Options (Right to Buy)	06/03/2022	06/03/2029	Class A ordinary share	5,710	$0.1	D
Options (Right to Buy)	06/03/2023	06/03/2029	Class A ordinary share	5,710	$0.1	D
Options (Right to Buy)	06/03/2020	06/03/2029	Class A ordinary share	3,079	$0.1	D
Options (Right to Buy)	06/03/2021	06/03/2029	Class A ordinary share	16,991	$0.1	D
Options (Right to Buy)	06/03/2022	06/03/2029	Class A ordinary share	16,991	$0.1	D
Options (Right to Buy)	06/03/2023	06/03/2029	Class A ordinary share	16,991	$0.1	D
Options (Right to Buy)	06/03/2021	06/03/2029	Class A ordinary share	92,565	$0.1	D
Options (Right to Buy)	06/03/2022	06/03/2029	Class A ordinary share	171,297	$0.1	D
Options (Right to Buy)	06/03/2023	06/03/2029	Class A ordinary share	171,298	$0.1	D
Options (Right to Buy)	03/01/2020	03/01/2030	Class A ordinary share	928	$0.1	D
Options (Right to Buy)	06/03/2023	06/03/2029	Class A ordinary share	17,861	$0.1	D
Options (Right to Buy)	07/01/2023	07/01/2030	Class A ordinary share	83,193	$0.1	D
Options (Right to Buy)	07/01/2023	07/01/2030	Class A ordinary share	83,194	$0.1	D
Options (Right to Buy)	01/01/2024	01/01/2031	Class A ordinary share	135,000	$0.1	D
Options (Right to Buy)	01/01/2025	01/01/2031	Class A ordinary share	135,000	$0.1	D
Options (Right to Buy)	06/03/2022	06/03/2032	Class A ordinary share	3,333	$0.1	D
Options (Right to Buy)	(1)	01/01/2032	Class A ordinary share	182,605	$0.1	D
Options (Right to Buy)	01/01/2023	01/01/2033	Class A ordinary share	80,000	$0.1	D
Options (Right to Buy)	04/01/2024	04/01/2033	Class A ordinary share	7,276	$0.1	D
Options (Right to Buy)	06/03/2024	06/03/2033	Class A ordinary share	6,201	$0.1	D
Options (Right to Buy)	06/03/2024	06/03/2033	Class A ordinary share	33,291	$0.1	D
Options (Right to Buy)	06/03/2024	06/03/2033	Class A ordinary share	38,310	$0.1	D
Options (Right to Buy)	04/01/2025	04/01/2034	Class A ordinary share	7,048	$0.1	D
Options (Right to Buy)	06/03/2024	06/03/2034	Class A ordinary share	6,667	$0.1	D
Options (Right to Buy)	06/03/2025	06/03/2034	Class A ordinary share	77,642	$0.1	D
Options (Right to Buy)	07/01/2025	07/01/2035	Class A ordinary share	66,667	$0.1	D
Options (Right to Buy)	04/01/2026	04/01/2035	Class A ordinary share	6,966	$0.1	D

Explanation of Responses:

1. Represents options to purchase 182,605 Class A ordinary shares granted on January 1, 2022. The options vest in equal installments of 1/4 of the options on the January 1 of each year thereafter over the next 4 years, subject to the reporting person's continued service through the applicable vesting date.

	/s/ Wang Yongliang	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the ATRenew (RERE) Form 3 filing by Wang Yongliang show?

The Form 3 shows Executive President Wang Yongliang’s existing stock option holdings in ATRenew. It details multiple options on Class A ordinary shares with a $0.1000 exercise price and expirations stretching from 2029 through 2035, without reporting any new buy or sell transactions.

What are the key terms of Wang Yongliang’s largest ATRenew stock option grant?

A highlighted grant covers 182,605 Class A ordinary shares, awarded on January 1, 2022. These options vest in four equal 1/4 installments each January 1 over the next four years, subject to his continued service, and carry an exercise price of $0.1000 per share.

Does the ATRenew (RERE) Form 3 indicate insider buying or selling activity?

The Form 3 reflects holdings only and does not report explicit buy or sell transactions. It lists existing options with a $0.1000 exercise price and various expiration dates, serving as an initial statement of beneficial ownership rather than a record of recent trades.

What exercise price is disclosed for Wang Yongliang’s ATRenew stock options?

All listed options for Executive President Wang Yongliang show a conversion or exercise price of $0.1000 per Class A ordinary share. This price applies across numerous grants that expire between 2029 and 2035, according to the filing’s transaction and derivative summaries.

How do Wang Yongliang’s ATRenew options vest according to the Form 3 footnote?

For the 182,605-share grant dated January 1, 2022, the options vest in equal installments of one quarter of the total on each January 1 over the following four years. Vesting is conditioned on his continued service through each applicable vesting date.